NEW YORK, NY / ACCESSWIRE / March 12, 2018 / U.S. markets hiked higher on Friday, with the Dow Jones breaking above the 25,000 threshold, on the back of a stronger-than-expected jobs report. The Dow Jones Industrial Average gained 1.77 percent to close at 25,335.74, while the S&P 500 Index increased 1.74 percent to close at 2,786.57. The Nasdaq Composite Index jumped 1.79 percent to close at 7,560.81.
"You're getting strong jobs with not a lot of wage growth, which is perfect below expectations. And that’s what's sort of powering the futures right. It's the best of both worlds," said Robert Pavlik, chief investment strategist at SlateStone Wealth.
RDI Initiates Coverage on:
Novavax, Inc.'s stock edged 0.98% higher Friday, to close the day at $2.06. The stock recorded a trading volume of 4,631,481 shares, which was below its three months average volume of 11,972,380 shares. In the last year, Novavax, Inc.'s shares have traded in a range of 0.73 - 2.75. The share price has gained 182.19% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $2.13 is greater than its 200-day moving average of $1.46. Shares of Novavax have gained roughly 4.04 percent in the past month and are up 66.13 percent year-to-date.
Access RDI's Novavax, Inc. Research Report at:
On Friday, shares of Celgene Corporation recorded a trading volume of 6,365,905 shares, which was below the three months average volume of 7,619,068 shares. The stock ended the day 1.50% higher at 92.56. The stock is currently trading 37.11% below its 52 week high with a 52 week trading range of 86.55 - 147.17. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $95.57 is below its 200-day moving average of $113.10. Shares of Celgene Corporation are trading at a Price to Earnings ratio of 25.43. Shares of Celgene have gained roughly 0.05 percent in the past month and are down 11.31 percent year-to-date.
Access RDI's Celgene Corporation Research Report at:
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Nadia Noorani, CFA® charter holder. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
For any questions, inquiries, or comments reach out to us directly at:
Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.